OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeted protein degraders march towards the clinic for neurodegenerative diseases
Dhiraj Kumar, Md. Imtaiyaz Hassan
Ageing Research Reviews (2022) Vol. 78, pp. 101616-101616
Closed Access | Times Cited: 28
Dhiraj Kumar, Md. Imtaiyaz Hassan
Ageing Research Reviews (2022) Vol. 78, pp. 101616-101616
Closed Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Research in the Field of Drug Design and Development
Grażyna Biała, Ewa Kędzierska, Marta Kruk-Słomka, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1283-1283
Open Access | Times Cited: 24
Grażyna Biała, Ewa Kędzierska, Marta Kruk-Słomka, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1283-1283
Open Access | Times Cited: 24
Biochemical features and therapeutic potential of α-Mangostin: Mechanism of action, medicinal values, and health benefits
Manzar Alam, Summya Rashid, Kisa Fatima, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114710-114710
Open Access | Times Cited: 21
Manzar Alam, Summya Rashid, Kisa Fatima, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114710-114710
Open Access | Times Cited: 21
PROTACs in the Management of Prostate Cancer
Yedla Poornachandra, Ahmad O. Babalghith, Vindhya Vasini Andra, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3698-3698
Open Access | Times Cited: 15
Yedla Poornachandra, Ahmad O. Babalghith, Vindhya Vasini Andra, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3698-3698
Open Access | Times Cited: 15
Potential of the nanoplatform and PROTAC interface to achieve targeted protein degradation through the Ubiquitin–Proteasome system
Hanshu Xie, Chao Zhang
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116168-116168
Closed Access | Times Cited: 5
Hanshu Xie, Chao Zhang
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116168-116168
Closed Access | Times Cited: 5
Proteostasis in aging-associated ocular disease
Jasper Weinberg, Mohita Gaur, Anand Swaroop, et al.
Molecular Aspects of Medicine (2022) Vol. 88, pp. 101157-101157
Open Access | Times Cited: 25
Jasper Weinberg, Mohita Gaur, Anand Swaroop, et al.
Molecular Aspects of Medicine (2022) Vol. 88, pp. 101157-101157
Open Access | Times Cited: 25
A review on cyclin-dependent kinase 5: An emerging drug target for neurodegenerative diseases
Shivani Batra, Shagufta Jahan, Anam Ashraf, et al.
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123259-123259
Closed Access | Times Cited: 13
Shivani Batra, Shagufta Jahan, Anam Ashraf, et al.
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123259-123259
Closed Access | Times Cited: 13
Targeting epigenetic modifications in Parkinson's disease therapy
Dan Zhang, Jifa Zhang, Yuxi Wang, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1748-1777
Closed Access | Times Cited: 13
Dan Zhang, Jifa Zhang, Yuxi Wang, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1748-1777
Closed Access | Times Cited: 13
Emerging therapeutic developments in neurodegenerative diseases: A clinical investigation
Dhiraj Kumar, Ghulam Md Ashraf, Anwar L. Bilgrami, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 10, pp. 103305-103305
Closed Access | Times Cited: 20
Dhiraj Kumar, Ghulam Md Ashraf, Anwar L. Bilgrami, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 10, pp. 103305-103305
Closed Access | Times Cited: 20
Zinc-dependent deacetylases (HDACs) as potential targets for treating Alzheimer’s disease
Yan Li, Shuxian Lin, Zhicheng Gu, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 76, pp. 129015-129015
Closed Access | Times Cited: 20
Yan Li, Shuxian Lin, Zhicheng Gu, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 76, pp. 129015-129015
Closed Access | Times Cited: 20
Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease
Yan Li, Zhicheng Gu, Shuxian Lin, et al.
Brain Sciences (2022) Vol. 12, Iss. 5, pp. 672-672
Open Access | Times Cited: 19
Yan Li, Zhicheng Gu, Shuxian Lin, et al.
Brain Sciences (2022) Vol. 12, Iss. 5, pp. 672-672
Open Access | Times Cited: 19
Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases
Lan Zhang, Yi Liu, Yingying Lu, et al.
Biochemical Pharmacology (2022) Vol. 206, pp. 115295-115295
Closed Access | Times Cited: 19
Lan Zhang, Yi Liu, Yingying Lu, et al.
Biochemical Pharmacology (2022) Vol. 206, pp. 115295-115295
Closed Access | Times Cited: 19
Central Nervous System Targeted Protein Degraders
Bedwyr ab Ion Thomas, H Lewis, D. Heulyn Jones, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1164-1164
Open Access | Times Cited: 10
Bedwyr ab Ion Thomas, H Lewis, D. Heulyn Jones, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1164-1164
Open Access | Times Cited: 10
Targeting inhibition of microtubule affinity regulating kinase 4 by Harmaline: Strategy to combat Alzheimer's disease
Mohd Adnan, Saleha Anwar, Debarati DasGupta, et al.
International Journal of Biological Macromolecules (2022) Vol. 224, pp. 188-195
Closed Access | Times Cited: 16
Mohd Adnan, Saleha Anwar, Debarati DasGupta, et al.
International Journal of Biological Macromolecules (2022) Vol. 224, pp. 188-195
Closed Access | Times Cited: 16
Proximity-Induced Pharmacology for Amyloid-Related Diseases
Andrea Bertran-Mostazo, Gabrielė Putriūtė, Irene Álvarez-Berbel, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 449-449
Open Access | Times Cited: 2
Andrea Bertran-Mostazo, Gabrielė Putriūtė, Irene Álvarez-Berbel, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 449-449
Open Access | Times Cited: 2
Recent advances in the in vitro and in vivo methods to assess impact of P‐glycoprotein and breast cancer resistance protein transporters in central nervous system drug disposition
Sagnik Chatterjee, Anup Deshpande, Hong Shen
Biopharmaceutics & Drug Disposition (2023) Vol. 44, Iss. 1, pp. 7-25
Closed Access | Times Cited: 7
Sagnik Chatterjee, Anup Deshpande, Hong Shen
Biopharmaceutics & Drug Disposition (2023) Vol. 44, Iss. 1, pp. 7-25
Closed Access | Times Cited: 7
Albumin-encapsulated HSP90-PROTAC BP3 nanoparticles not only retain protein degradation ability but also enhance the antitumour activity of BP3 in vivo
Qingna Jiang, Yan Hu, Quanyu Liu, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 4, pp. 411-420
Closed Access | Times Cited: 6
Qingna Jiang, Yan Hu, Quanyu Liu, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 4, pp. 411-420
Closed Access | Times Cited: 6
A Perspective on Newly Emerging Proteolysis-Targeting Strategies in Antimicrobial Drug Discovery
Janarthanan Venkatesan, Dhanashree Murugan, Loganathan Rangasamy
Antibiotics (2022) Vol. 11, Iss. 12, pp. 1717-1717
Open Access | Times Cited: 10
Janarthanan Venkatesan, Dhanashree Murugan, Loganathan Rangasamy
Antibiotics (2022) Vol. 11, Iss. 12, pp. 1717-1717
Open Access | Times Cited: 10
Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes
Janarthanan Venkatesan, Dhanashree Murugan, Kalaiarasu Lakshminarayanan, et al.
Pharmacology & Therapeutics (2024) Vol. 263, pp. 108725-108725
Closed Access | Times Cited: 1
Janarthanan Venkatesan, Dhanashree Murugan, Kalaiarasu Lakshminarayanan, et al.
Pharmacology & Therapeutics (2024) Vol. 263, pp. 108725-108725
Closed Access | Times Cited: 1
Unveiling the role of histone deacetylases in neurological diseases: focus on epilepsy
Danfeng Cao, Xinyu Zhou, Qian Guo, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Danfeng Cao, Xinyu Zhou, Qian Guo, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease
Yan Li, Zhicheng Gu, Shu-xian Lin, et al.
(2022)
Open Access | Times Cited: 6
Yan Li, Zhicheng Gu, Shu-xian Lin, et al.
(2022)
Open Access | Times Cited: 6
The Role of Post-Translational Protein Acetylation and Deacetylation in the Apoptosis of Neurons of the Peripheral Nervous System
Valentina Dzreyan, Svetlana Demyanenko
Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology (2023) Vol. 17, Iss. 4, pp. 249-263
Closed Access | Times Cited: 2
Valentina Dzreyan, Svetlana Demyanenko
Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology (2023) Vol. 17, Iss. 4, pp. 249-263
Closed Access | Times Cited: 2
Powering Up Targeted Protein Degradation Through Active and Passive Tumour-Targeting Strategies: Current and Future Scopes
Janarthanan Venkatesan, Dhanashree Murugan, Kalaiarasu Lakshminarayanan, et al.
(2024)
Closed Access
Janarthanan Venkatesan, Dhanashree Murugan, Kalaiarasu Lakshminarayanan, et al.
(2024)
Closed Access
Osmolytes as a Promising Therapeutic Strategy for Protein Aggregation Diseases
Sumaiya Khan, Md. Imtaiyaz Hassan, Faizan Ahmad, et al.
(2024), pp. 73-88
Closed Access
Sumaiya Khan, Md. Imtaiyaz Hassan, Faizan Ahmad, et al.
(2024), pp. 73-88
Closed Access
Novel Prospects in Targeting Neurodegenerative Disorders via Autophagy
Shumayila Khan, Saurabh Upadhyay, Md. Imtaiyaz Hassan
European Journal of Pharmacology (2024) Vol. 984, pp. 177060-177060
Closed Access
Shumayila Khan, Saurabh Upadhyay, Md. Imtaiyaz Hassan
European Journal of Pharmacology (2024) Vol. 984, pp. 177060-177060
Closed Access
Targeted protein degradation: expanding the technology to facilitate the clearance of neurotoxic proteins in neurodegenerative diseases
Xin Wang, Shuai Wen, Panpan Yang, et al.
Ageing Research Reviews (2024), pp. 102584-102584
Closed Access
Xin Wang, Shuai Wen, Panpan Yang, et al.
Ageing Research Reviews (2024), pp. 102584-102584
Closed Access
